Jim Cramer Says ‘Price Controls Are Not Like Tariffs’ — Urges Drugmakers To Challenge Trump’s Plan With ‘Injunction’

CNBC Commentator, Jim Cramer has raised concerns over the constitutionality of recent drug price controls, urging pharmaceutical companies to seek an injunction.

read more